Tag: cjc-1295

CJC-1295 acts on the GHRH receptor. Ipamorelin acts on the ghrelin receptor. Together they trigger a synergistic GH pulse that neither produces as effectively alone — and Ipamorelin's selectivity means you don't get the cortisol and prolactin side effects of older secretagogues.

CJC-1295 targets the GHRH receptor. Ipamorelin targets the ghrelin receptor. They produce a synergistic GH pulse through two independent pathways — and Ipamorelin does it without the cortisol and prolactin elevation that made older GH secretagogues problematic.